Does TADALAFIL Cause Product substitution issue? 190 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Product substitution issue have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 0.6% of all adverse event reports for TADALAFIL.
190
Reports of Product substitution issue with TADALAFIL
0.6%
of all TADALAFIL reports
0
Deaths
11
Hospitalizations
How Dangerous Is Product substitution issue From TADALAFIL?
Of the 190 reports, 11 (5.8%) required hospitalization.
Is Product substitution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 190 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Product substitution issue?
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832)
BUPROPION (1,578)
METHYLPHENIDATE (1,408)
CLONAZEPAM (1,288)
LAMOTRIGINE (979)
ALBUTEROL (864)
LEVOTHYROXINE (803)
DULOXETINE (766)
ESTRADIOL (692)
SERTRALINE (636)
Which TADALAFIL Alternatives Have Lower Product substitution issue Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR